Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
Clinical trial NCT05707949 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05707949
- Sponsor
- AbbVie
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2032-04-01
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.